Shane Darke

Shane Darke

Auto-generated profile, based on publicly available information

Shane Darke

National Drug and Alcohol Research Centre University of New South Wales Sydney Australia

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2008 in Drug and Alcohol Review
Verified
Journal Article
Closed access
PDF file
SDShane Darke
Shane Darke
SKSharlene Kaye
Sharlene Kaye
RMREBECCA McKETIN
REBECCA McKETIN
JDJohan Duflou
Johan Duflou
Issues. The major physical and psychological health effects of methamphetamine use, and the factors associated with such harms. Approach. Comprehensive review. Key Findings. Physical harms reviewed included toxicity and mortality, cardiovascular/cerebrovascular pathology, dependence and blood‐borne virus transmission. Psychological harms include methamphetamine psychosis, depression, suicide, anxiety and violent behaviours. Implications. While high‐profile health consequences, such as psychosis, are given prominence in the public debate, the negative sequelae extend far beyond this. This is a drug class that causes serious heart disease, has serious dependence liability and high rates of suicidal behaviours. Conclusion. The current public image of methamphetamine does not portray adequately the extensive, and in many cases insidious, harms caused.

28 April 2020 in Addiction
Verified
Journal Article
Open access
PDF file
JMJohn Marsden
John Marsden
SDShane Darke
Shane Darke
WHWayne Hall
Wayne Hall
MHMatt Hickman
Matt Hickman
JHJohn Holmes
John Holmes
RWRobert West
Robert West
Click on the book chapter title to read more.

28 July 2002 in Addiction
Verified
Journal Article
Closed access
PDF file
MWMatthew Warner‐Smith
Matthew Warner‐Smith
SDShane Darke
Shane Darke
CDCarolyn Day
Carolyn Day

4 May 2023 in Addiction
Verified
Journal Article
Open access
CBChrianna Bharat
Chrianna Bharat
PWPaige Webb
Paige Webb
ZWZachary Wilkinson
Zachary Wilkinson
RMRebecca McKetin
Rebecca McKetin
JGJason Grebely
Jason Grebely
LDLouisa Degenhardt
Louisa Degenhardt
Background and Aims: Studies often rely upon self‐report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self‐report instruments. We aimed to examine comprehensively the evidence for agreement between self‐reported and biologically measured illicit drug use among all major illicit drug classes, biological indicators, populations and settings.Methods: We systematically searched peer‐reviewed databases (Medline, Embase and PsycINFO) and grey literature. Included studies reported 2 × 2 table counts or agreement estimates comparing self‐reported and biologically measured use published up to March 2022. With biological results considered to be the reference standard and use of random‐effect regression models, we evaluated pooled estimates for overall agreement (primary outcome), sensitivity, specificity, false omission rates (proportion reporting no use that test positive) and false discovery rates (proportion reporting use that test negative) by drug class, potential consequences attached to self‐report (i.e. work, legal or treatment impacts) and time‐frame of use. Heterogeneity was assessed by inspecting forest plots.Results: From 7924 studies, we extracted data from 207 eligible studies. Overall agreement ranged from good to excellent (> 0.79). False omission rates were generally low, while false discovery rates varied by setting. Specificity was generally high but sensitivity varied by drug, sample type and setting. Self‐report in clinical trials and situations of no consequences was generally reliable. For urine, recent (i.e. past 1–4 days) self‐report produced lower sensitivity and false discovery rates than past month. Agreement was higher in studies that informed participants biological testing would occur (diagnostic odds ratio = 2.91, 95% confidence interval = 1.25–6.78). The main source of bias was biological assessments (51% studies).Conclusions: While there are limitations associated with self‐report and biological testing to measure illicit drug use, overall agreement between the two methods is high, suggesting both provide good measures of illicit drug use. Recommended methods of biological testing are more likely to provide reliable measures of recent use if there are problems with self‐disclosure.


15 January 2009 in Addiction
Verified
Journal Article
Closed access
PDF file
JSJames Shearer
James Shearer
SDShane Darke
Shane Darke
CRCraig Rodgers
Craig Rodgers
TSTim Slade
Tim Slade
IBIngrid Van Beek
Ingrid Van Beek
AWAlex Wodak
Alex Wodak